Aberrant expression of AKR1B1 indicates poor prognosis and promotes gastric cancer progression by regulating the AKT-mTOR pathway.

Liu, Luojie; Zhu, Lihua; Cheng, Zhengwu; Sun, Yibin; Zhou, Yuqing; Cao, Jiwei

Liu, Luojie; Zhu, Lihua; Cheng, Zhengwu; Sun, Yibin; Zhou, Yuqing; Cao, Jiwei.

Afiliación

Liu L; Department of Gastroenterology, Changshu Hospital Affiliated to Soochow University, Suzhou 215501, China.
Zhu L; Department of Gastroenterology, Changshu Hospital Affiliated to Soochow University, Suzhou 215501, China.
Cheng Z; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wannan Medical College, Wuhu 241000, China.
Sun Y; Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu 215005, China.
Zhou Y; Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu 215005, China.
Cao J; Department of General Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu 215005, China.

Aging (Albany NY) ; 15(18): 9661-9675, 2023 Sep 24.

Article en En | MEDLINE | ID: mdl-37751590

Palabras clave

AKR1B1; AKT-mTOR pathway; gastric cancer; prognosis; proliferation and migration

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Aging (Albany NY) Asunto de la revista: GERIATRIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google